We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Oscar Health (OSCR) Q3 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that Oscar Health, Inc. (OSCR - Free Report) will report quarterly loss of -$0.11 per share in its upcoming release, pointing to a year-over-year increase of 79.3%. It is anticipated that revenues will amount to $4.72 billion, exhibiting an increase of 58.1% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Oscar Health metrics that are commonly monitored and projected by Wall Street analysts.
Based on the collective assessment of analysts, 'Revenue- Premium' should arrive at $4.66 billion. The estimate indicates a year-over-year change of +59.3%.
According to the collective judgment of analysts, 'Revenue- Investment income' should come in at $58.14 million. The estimate suggests a change of +9.3% year over year.
The collective assessment of analysts points to an estimated 'Membership by Offering- Individual and Small Group' of 2.70 million. Compared to the current estimate, the company reported 2.11 million in the same quarter of the previous year.
The average prediction of analysts places 'Medical loss ratio' at 85.1%. Compared to the present estimate, the company reported 88.5% in the same quarter last year.
Shares of Oscar Health have experienced a change of -1.8% in the past month compared to the -0.9% move of the Zacks S&P 500 composite. With a Zacks Rank #1 (Strong Buy), OSCR is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Unveiling Oscar Health (OSCR) Q3 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Oscar Health, Inc. (OSCR - Free Report) will report quarterly loss of -$0.11 per share in its upcoming release, pointing to a year-over-year increase of 79.3%. It is anticipated that revenues will amount to $4.72 billion, exhibiting an increase of 58.1% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Oscar Health metrics that are commonly monitored and projected by Wall Street analysts.
Based on the collective assessment of analysts, 'Revenue- Premium' should arrive at $4.66 billion. The estimate indicates a year-over-year change of +59.3%.
According to the collective judgment of analysts, 'Revenue- Investment income' should come in at $58.14 million. The estimate suggests a change of +9.3% year over year.
The collective assessment of analysts points to an estimated 'Membership by Offering- Individual and Small Group' of 2.70 million. Compared to the current estimate, the company reported 2.11 million in the same quarter of the previous year.
The average prediction of analysts places 'Medical loss ratio' at 85.1%. Compared to the present estimate, the company reported 88.5% in the same quarter last year.
View all Key Company Metrics for Oscar Health here>>>Shares of Oscar Health have experienced a change of -1.8% in the past month compared to the -0.9% move of the Zacks S&P 500 composite. With a Zacks Rank #1 (Strong Buy), OSCR is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .